Literature DB >> 18080359

A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.

R Gabe1, L Tryggvadóttir, B F Sigfússon, G H Olafsdóttir, K Sigurdsson, S W Duffy.   

Abstract

BACKGROUND: The Icelandic breast cancer screening program, initiated November 1987 in Reykjavik and covering the whole country from December 1989, comprises biennial invitation to mammography for women aged 40-69 years old.
PURPOSE: To estimate the impact of mammography service screening in Iceland on deaths from breast cancer.
MATERIAL AND METHODS: Cases were deaths from breast cancer from 1990 onwards in women aged 40 and over at diagnosis, during the period November 1987 to December 31, 2002. Age- and screening-area-matched, population-based controls were women who had also been invited to screening but were alive at the time their case died.
RESULTS: Using conditional logistic regression on the data from 226 cases and 902 controls, the odds ratio for the risk of death from breast cancer in those attending at least one screen compared to those never screened was 0.59 (95% CI 0.41-0.84). After adjustment for healthy-volunteer bias and screening-opportunity bias, the odds ratio was 0.65 (95% CI 0.39-1.09).
CONCLUSION: These results indicate a 35-40% reduction in breast cancer deaths by attending the Icelandic breast cancer screening program. These results are consistent with the overall evidence from other observational evaluations of mammography-based programs.

Entities:  

Mesh:

Year:  2007        PMID: 18080359     DOI: 10.1080/02841850701501725

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

1.  Residual confounding after adjustment for age: a minor issue in breast cancer screening effectiveness.

Authors:  Guido van Schoor; Ellen Paap; Mireille J M Broeders; André L M Verbeek
Journal:  Eur J Epidemiol       Date:  2011-04-26       Impact factor: 8.082

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Advantages and Disadvantages of Mammography Screening.

Authors:  Sylvia H Heywang-Köbrunner; Astrid Hacker; Stefan Sedlacek
Journal:  Breast Care (Basel)       Date:  2011-05-27       Impact factor: 2.860

4.  Breast cancer mortality in relation to receipt of screening mammography: a case-control study in Saskatchewan, Canada.

Authors:  Gaia Pocobelli; Noel S Weiss
Journal:  Cancer Causes Control       Date:  2014-12-04       Impact factor: 2.506

5.  Population-based service mammography screening: the Icelandic experience.

Authors:  Kristjan Sigurdsson; Elínborg Jóna Olafsdóttir
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-05-09

6.  Breast cancer screening: are we seeing the benefit?

Authors:  Donella Puliti; Marco Zappa
Journal:  BMC Med       Date:  2012-09-20       Impact factor: 8.775

7.  Increasingly strong reduction in breast cancer mortality due to screening.

Authors:  G van Schoor; S M Moss; J D M Otten; R Donders; E Paap; G J den Heeten; R Holland; M J M Broeders; A L M Verbeek
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

8.  Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.

Authors:  Ondrej Majek; Jan Danes; Miroslava Skovajsova; Helena Bartonkova; Lucie Buresova; Daniel Klimes; Petr Brabec; Pavel Kozeny; Ladislav Dusek
Journal:  BMC Public Health       Date:  2011-05-10       Impact factor: 3.295

9.  Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.

Authors:  I Parvinen; S Heinävaara; A Anttila; H Helenius; P Klemi; L Pylkkänen
Journal:  Br J Cancer       Date:  2015-02-17       Impact factor: 7.640

10.  A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.

Authors:  P C Allgood; J Warwick; R M L Warren; N E Day; S W Duffy
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.